FDA Warning Letter — DISTACART

Case 716212 — FEI 3039322402

The FDA took a Warning Letter action against DISTACART on Nov 17, 2025 (Mountain View, CA). The action was issued by CDER and concerns drugs products.

Action details

Facility
DISTACART
Date
Nov 17, 2025
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Mountain View, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.